On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation
Sponsored by Benha University
About this trial
Last updated 9 months ago
Study ID
Ms13-3-2024
Status
Completed
Type
Interventional
Phase
Phase 2
Placebo
No
Accepting
25 to 65 Years
Male
Trial Timing
Ended a year ago
What is this trial about?
Both Silodosin 4 mg and Dapoxetine 60 mg significantly improved IELT and sexual function scores in primary PE patients. However, Silodosin exhibited a more favorable tolerability profile with fewer side effects, making it a safer, clinically effective alternative.
What are the participation requirements?
Inclusion Criteria
* Heterosexual male
* Sexually active
* Aged 25 to 65 years old.
* Primary premature ejaculation (IELT < 1 minute)
* They had experienced PE for a minimum of 6 months
Exclusion Criteria
* Patients with a history of diabetes or
* Uncontrolled hypertension (systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg) was precluded from the study.
* Anatomic abnormalities of the penis or genital region,
* Erectile dysfunction,
* Chronic prostatitis,
* Psychological disorder
* Patients on anti-psychotic drugs.